By Dr Ciaran Sewter and Dr Mark Evans, Development Scientists, and Dr Elizabeth Hill, Chief Executive Officer at 3D Molecular Sciences Ltd
Dr Ciaran Sewter is a Development Scientist at 3D Molecular Sciences Ltd. He has a BSc in Biological Sciences from the University of East Anglia and a PhD from the University of Cambridge.
Dr Sewter has expertise in molecular and cell biology and has held a number of academic and industrial positions in obesity/diabetes research, immunology and virology.
Dr Mark Evans works as a Development Scientist at 3D Molecular Sciences Ltd. Having completed his first degree in Biochemistry at the University of Plymouth, Dr Evans obtained a PhD from the Department of Analytical Chemistry at Loughborough University, based on the development of biospecific assays for drugs of pharmaceutical interest. After two years as a Research Fellow, he became Head of Assay Automation at Kalibrant Ltd, before joining 3D Molecular Sciences in October 2002. His main areas of expertise are fluidics, instrumentation, automation, solid state devices and fluorescence.
Dr Elizabeth Hill is Chief Executive Officer and Co-Founder of 3D Molecular Sciences Ltd. She has 20 years' experience in the biotechnology, life sciences and health care sectors. Dr Hill started her career in instrumentation with Philips Scientific, subsequently moving into biotechnology, where she was a principal participant in the MBO of Enzymatix leading to Chiroscience and Celsis, and the subsequent IPO of the latter. She graduated with a First Class Honours degree in Chemistry and was awarded a PhD at King's College London for developing electrochemiluminescence as a detection technique for HPLC.
|
|
